These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7734258)

  • 1. Pharmacodynamics of the 1R cis-1'R cis isomer of atracurium (51W89) in health and chronic renal failure.
    Boyd AH; Eastwood NB; Parker CJ; Hunter JM
    Br J Anaesth; 1995 Apr; 74(4):400-4. PubMed ID: 7734258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of 51W89: preliminary data.
    Hunter JM; Eastwood NB; Boyd AH; Parker CJ
    Acta Anaesthesiol Scand Suppl; 1995; 106():94. PubMed ID: 8533555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of 1R-cis 1'R-cis atracurium besylate (51W89) and plasma laudanosine concentrations in health and chronic renal failure.
    Eastwood NB; Boyd AH; Parker CJ; Hunter JM
    Br J Anaesth; 1995 Oct; 75(4):431-5. PubMed ID: 7488483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit.
    Boyd AH; Eastwood NB; Parker CJ; Hunter JM
    Br J Anaesth; 1996 Mar; 76(3):382-8. PubMed ID: 8785138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intubating conditions following 1R CIS, 1'R CIS atracurium (51W89). A comparison with atracurium.
    Littlejohn IH; Abhay K; el Sayed A; Broomhead CJ; Duvaldestin P; Flynn PJ
    Anaesthesia; 1995 Jun; 50(6):499-502. PubMed ID: 7618661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the infusion pharmacokinetics and pharmacodynamics of cisatracurium, the 1R-cis 1'R-cis isomer of atracurium, with atracurium besylate in healthy patients.
    Smith CE; van Miert MM; Parker CJ; Hunter JM
    Anaesthesia; 1997 Sep; 52(9):833-41. PubMed ID: 9349062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia.
    Lien CA; Belmont MR; Abalos A; Eppich L; Quessy S; Abou-Donia MM; Savarese JJ
    Anesthesiology; 1995 May; 82(5):1131-8. PubMed ID: 7537945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic effects of 51W89, an isomer of atracurium, in children during halothane anaesthesia.
    Meretoja OA; Taivainen T; Wirtavuori K
    Br J Anaesth; 1995 Jan; 74(1):6-11. PubMed ID: 7880708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia.
    Belmont MR; Lien CA; Quessy S; Abou-Donia MM; Abalos A; Eppich L; Savarese JJ
    Anesthesiology; 1995 May; 82(5):1139-45. PubMed ID: 7741288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cisatracurium].
    Ortiz JR; Percaz JA; Carrascosa F
    Rev Esp Anestesiol Reanim; 1998; 45(6):242-7. PubMed ID: 9719722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of cisatracurium in patients with end-stage liver disease undergoing liver transplantation.
    De Wolf AM; Freeman JA; Scott VL; Tullock W; Smith DA; Kisor DF; Kerls S; Cook DR
    Br J Anaesth; 1996 May; 76(5):624-8. PubMed ID: 8688259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinical pharmacology of cisatracurium].
    Mellinghoff H; Diefenbach C
    Anaesthesist; 1997 Jun; 46(6):481-5. PubMed ID: 9297378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of urinary and biliary conjugated metabolites of the neuromuscular blocker 51W89 by liquid chromatography/mass spectrometry.
    Dear GJ; Harrelson JC; Jones AE; Johnson TE; Pleasance S
    Rapid Commun Mass Spectrom; 1995; 9(14):1457-64. PubMed ID: 8534894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cis-atracurium--an equivalent substitution for atracurium in pediatric anesthesia?].
    Voss J; Riedel T; Sommer M; Rosolski T
    Anaesthesiol Reanim; 2002; 27(4):93-7. PubMed ID: 12238266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of neuromuscular blockade by mivacurium and atracurium].
    Hofmockel R; Benad G; Jantschulev S
    Anaesthesiol Reanim; 1995; 20(1):4-11. PubMed ID: 8526957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of atracurium and vecuronium on the latency and the duration of the negative deflection of the evoked compound action potential of the adductor pollicis.
    Pugh ND; Harper NJ; Healy TE; Petts HV
    Br J Anaesth; 1987 Feb; 59(2):195-9. PubMed ID: 2881565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dose-response relationship of atracurium in underweight, normal and overweight patients].
    Blobner M; Felber AR; Schneck HJ; Jelen-Esselborn S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1994 Oct; 29(6):338-42. PubMed ID: 7999935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Accuracy and dose dependency of the train-of-four count].
    Krombach J; Krieg N; Diefenbach C
    Anaesthesist; 1999 Aug; 48(8):519-22. PubMed ID: 10506315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of atracurium by pancuronium during propofol-fentanyl-N2O anesthesia.
    Nathan N; Bonada G; Feiss P
    Acta Anaesthesiol Belg; 1996; 47(4):187-93. PubMed ID: 9093646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.